{"id":"https://openalex.org/W2784040935","doi":null,"title":"Hepatitis C Medicines: Technology and Market Landscape","display_name":"Hepatitis C Medicines: Technology and Market Landscape","alternate_titles":[],"publication_year":2015,"publication_date":"2015-01-01","ids":{"openalex":"https://openalex.org/W2784040935","mag":"2784040935"},"language":"en","primary_location":{"id":"mag:2784040935","doi":null,"is_oa":false,"landing_page_url":"https://marketbookshelf.com/publications/hepatitis-c-medicines-technology-market-landscape/","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null},"parent_works":[],"lineage":["https://openalex.org/W2784040935"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5062733946","display_name":"Isbell Mike","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Isbell Mike","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057053072","display_name":"Ren\u00e9e Ridzon","orcid":"https://orcid.org/0000-0002-2822-8897","observed_orcids":["https://orcid.org/0000-0002-2822-8897"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Ren\u00e9e Ridzon","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5058433902","display_name":"Karin Timmermans","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Karin Timmermans","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.029,"has_fulltext":false,"cited_by_count":4,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.81758389,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":93},"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.6195999979972839,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.6195999979972839,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10151","display_name":"Hepatitis C virus research","score":0.3765000104904175,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.001500000013038516,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hepatitis-c","display_name":"hepatitis C","score":0.8629999756813049},{"id":"https://openalex.org/keywords/antiviral-drug-discovery","display_name":"antiviral drug discovery","score":0.6380000114440918},{"id":"https://openalex.org/keywords/drug-market-dynamics","display_name":"drug market dynamics","score":0.5490000247955322},{"id":"https://openalex.org/keywords/market-failure","display_name":"market failure","score":0.5699999928474426},{"id":"https://openalex.org/keywords/drug-affordability","display_name":"drug affordability","score":0.7129999995231628},{"id":"https://openalex.org/keywords/access-to-medicines","display_name":"access to medicines","score":0.7820000052452087},{"id":"https://openalex.org/keywords/hiv-coinfection","display_name":"HIV coinfection","score":0.7200000286102295},{"id":"https://openalex.org/keywords/market-based-interventions","display_name":"market-based interventions","score":0.7160000205039978},{"id":"https://openalex.org/keywords/viral-hepatitis","display_name":"viral hepatitis","score":0.4359999895095825}],"concepts":[{"id":"https://openalex.org/C27415008","wikidata":"https://www.wikidata.org/wiki/Q7256382","display_name":"Psychological intervention","level":2,"score":0.6169933080673218},{"id":"https://openalex.org/C2776455275","wikidata":"https://www.wikidata.org/wiki/Q154869","display_name":"Hepatitis C","level":2,"score":0.5996474623680115},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.500072717666626},{"id":"https://openalex.org/C2776408679","wikidata":"https://www.wikidata.org/wiki/Q708693","display_name":"Hepatitis C virus","level":3,"score":0.4710158109664917},{"id":"https://openalex.org/C138816342","wikidata":"https://www.wikidata.org/wiki/Q189603","display_name":"Public health","level":2,"score":0.42357444763183594},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.39361605048179626},{"id":"https://openalex.org/C144133560","wikidata":"https://www.wikidata.org/wiki/Q4830453","display_name":"Business","level":0,"score":0.37963080406188965},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.21487265825271606},{"id":"https://openalex.org/C2522874641","wikidata":"https://www.wikidata.org/wiki/Q808","display_name":"Virus","level":2,"score":0.0},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.0},{"id":"https://openalex.org/C159110408","wikidata":"https://www.wikidata.org/wiki/Q121176","display_name":"Nursing","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:2784040935","doi":null,"is_oa":false,"landing_page_url":"https://marketbookshelf.com/publications/hepatitis-c-medicines-technology-market-landscape/","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.8560000061988831,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":5,"referenced_works":["https://openalex.org/W1569419857","https://openalex.org/W2054938157","https://openalex.org/W2078251659","https://openalex.org/W2141769755","https://openalex.org/W2163848297"],"related_works":["https://openalex.org/W2784219906","https://openalex.org/W2789057280","https://openalex.org/W2966256605","https://openalex.org/W2782843532","https://openalex.org/W2526409101","https://openalex.org/W3112113824","https://openalex.org/W2899881357","https://openalex.org/W3109176633","https://openalex.org/W4233110787","https://openalex.org/W2276887418"],"abstract_inverted_index":{"UNITAID":[0,26,134],"supports":[1],"market-based":[2,24],"interventions":[3,242],"to":[4,7,65,139,185,243,246],"improve":[5],"access":[6,245],"medicines,":[8],"diagnostics":[9],"and":[10,19,46,54,61,95,116,122,145,179,195,212,220,234,249],"preventive":[11],"commodities":[12,31],"for":[13,58,78,191],"human":[14],"immunodeficiency":[15],"virus":[16,84],"(HIV),":[17],"tuberculosis":[18],"malaria.":[20],"To":[21],"help":[22],"identify":[23,62],"interventions,":[25],"analyses":[27],"the":[28,44,48,55,73,79,93,104,133,153,158,174,186,216,230,235],"market":[29,45,52,59,89,203,241],"of":[30,32,41,76,81,97,106,120,132,152,162,170,173,177,222],"interest.":[33],"These":[34],"analyses,":[35],"or":[36,188],"landscapes,":[37],"provide":[38],"an":[39,168,192],"overview":[40,169],"medicines":[42],"on":[43],"in":[47,229],"pipeline,":[49],"highlight":[50],"critical":[51],"shortcomings":[53],"underlying":[56],"reasons":[57],"failures,":[60],"potential":[63,240],"strategies":[64],"correct":[66],"them.":[67],"This":[69],"landscape":[70,176],"analysis":[71],"surveys":[72],"current":[74,171],"state":[75],"technologies":[77],"treatment":[80,101,198,232],"hepatitis":[82,143],"C":[83],"(HCV),":[85],"as":[86,88],"well":[87],"dynamics":[90,204],"that":[91,214],"affect":[92,215],"affordability":[94],"accessibility":[96],"HCV":[98,100,163,181,197,207,223,231,251],"therapeutics.":[99],"falls":[102],"within":[103],"ambit":[105],"UNITAID\u2019s":[107],"mission":[108],"because":[109],"it":[110],"is":[111],"a":[112,117,149],"major":[113],"HIV":[114],"coinfection":[115],"leading":[118],"cause":[119],"morbidity":[121],"mortality":[123],"among":[124],"people":[125],"living":[126],"with":[127,206],"HIV.":[128],"Strategic":[129],"Objective":[130],"3":[131,166],"Strategy":[135],"2013\u22122016":[136],"specifically":[137],"refers":[138],"viral":[140],"hepatitis,":[141],"notably":[142],"B":[144],"C.":[146],"Following":[148],"brief":[150],"description":[151],"methodology,":[154],"this":[155],"report":[156],"assesses":[157],"public":[159],"health":[160],"problem":[161],"infection.":[164],"Section":[165,200,225],"provides":[167],"knowledge":[172],"fast-evolving":[175],"approved":[178],"experimental":[180],"treatments,":[182,208],"comparing":[183],"each":[184],"ideal":[187],"target":[189],"profile":[190],"optimally":[193],"effective":[194,248],"scalable":[196],"regimen.":[199],"4":[201],"summarizes":[202],"associated":[205],"including":[209],"supply,":[210],"demand":[211],"factors":[213],"affordability,":[217],"accessibility,":[218],"uptake":[219],"sustainability":[221],"treatments.":[224],"5":[226],"identifies":[227],"weaknesses":[228],"market,":[233],"final":[236],"section":[237],"(6)":[238],"proposes":[239],"enhance":[244],"safe,":[247],"affordable":[250],"medicines.":[252]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2784040935","counts_by_year":[{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2015,"cited_by_count":1}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2018-01-26T00:00:00"}
